Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

364
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
364

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.

BJU international·2026
Same author

Spatiotemporal Medicare Reimbursement Trends and Economic Clusters in Otologic/Neurotologic Surgery.

The Laryngoscope·2026
Same author

Anthropometric Measurements Inform Complete Concentric Collapse Status in Patients With Obstructive Sleep Apnea.

OTO open·2026
Same author

Diagnostic Performance of the Stenvers and Pöschl Planes on CT in the Evaluation of Superior Semicircular Canal Dehiscence.

AJNR. American journal of neuroradiology·2026
Same author

Alternatives to radical cystectomy: a bladder-sparing approach in appropriately selected patients.

BJU international·2026
Same author

Otologic Surgery Risk Prediction: Risk Analysis Index-Administrative Versus Modified Frailty Index-5.

The Laryngoscope·2026
Same journal

Editorial Commentary.

Urology practice·2026
Same journal

Diagnostic Stewardship for Urinary Tract Infection in the United States: Why Evidence Must Drive Syndromic Panel Adoption.

Urology practice·2026
Same journal

Editorial Commentary.

Urology practice·2026
Same journal

Reply by authors.

Urology practice·2026
Same journal

The Impact of Patient-Provider Relationships on Prostate Cancer Screening: A Cross-Sectional Analysis of the All of Us Research Program.

Urology practice·2026
Same journal

Adjuvant Radiation Therapy Versus Initial Observation for Patients After Prostatectomy with Adverse Pathology: Have Findings from 3 Randomized Clinical Trials Influenced Clinical Practice?

Urology practice·2026
See all related articles

Related Experiment Video

Updated: Jun 29, 2025

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

14.3K

Prostate-Specific Antigen Screening in Smokers: A Comprehensive Analysis Using a National Behavioral Survey.

I Mitchell Harmatz1, Khalid Y Alkhatib1,2, Morgan Leff1

  • 1Division of Urology, University of Pennsylvania, Philadelphia, Pennsylvania.

Urology Practice
|April 2, 2024
PubMed
Summary
This summary is machine-generated.

Current smokers are less likely to get prostate cancer screening. Former smokers have similar screening rates to never smokers, suggesting targeted interventions are needed for current smokers to improve prostate cancer outcomes.

Keywords:
cigarette smokingpreventive medicineprostate-specific antigenprostatic neoplasmssmoking cessation

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.6K

Related Experiment Videos

Last Updated: Jun 29, 2025

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

14.3K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.6K

Area of Science:

  • Urology
  • Public Health
  • Oncology

Background:

  • Cigarette smoking is linked to aggressive prostate cancer and higher mortality.
  • Smokers are reportedly less likely to participate in prostate-specific antigen (PSA) screening.
  • Understanding this disparity is crucial for improving cancer outcomes.

Purpose of the Study:

  • To investigate the association between smoking status and guideline-concordant PSA screening.
  • To determine if current smokers are less likely to undergo recommended PSA screening compared to never smokers.

Main Methods:

  • Cross-sectional analysis of 58,996 men aged 55-69 from the 2018 Behavioral Risk Factor Surveillance System survey.
  • Used complex weighted multivariable Poisson regression to calculate adjusted prevalence and risk differences.
  • Examined data on cigarette smoking and PSA screening participation.

Main Results:

  • Overall PSA screening prevalence was 39%.
  • Current smokers had a significantly lower screening rate (27%) compared to never smokers (42%).
  • The adjusted relative risk for PSA screening was 0.81 for current smokers versus never smokers (P < .01).

Conclusions:

  • Current smokers are significantly less likely to undergo recommended PSA screening.
  • Former smokers showed similar screening rates to never smokers.
  • Interventions to boost screening in current smokers may improve prostate cancer diagnosis and outcomes.